Literature DB >> 10653296

Prosthetic reconstruction of the femur for primary bone sarcoma.

C H Gerrand1, D Currie, P Grigoris, R Reid, D L Hamblen.   

Abstract

The survival of patients and implants, complications and functional outcome were reviewed in 25 consecutive femoral endoprosthetic reconstructions for treatment of primary bone sarcoma. The diagnosis was chondrosarcoma in 11, osteosarcoma in 10, MFH in 3 and Ewing's tumour in 1. Median follow up was 64 months (34 to 219) and median age at operation was 29 years (10 to 70). Twelve remained disease free at review. One had amputation for local recurrence and another was alive with metastases. 11 patients died at a median of 13 months (5 to 128); 8 from metastatic disease and 3 from other causes. Four implants were revised, at a median of 95 months (53 to 136); two for fractures of the stem and two for aseptic loosening. Three implants had radiological evidence of loosening at a median of 43 months (34 to 49). Fourteen patients had significant complications. The median functional score using the Musculoskeletal Tumour Society system was 68%. In our experience, prosthetic reconstruction of the femur does not compromise survival, although there is a significant complication rate.

Entities:  

Mesh:

Year:  1999        PMID: 10653296      PMCID: PMC3619753          DOI: 10.1007/s002640050373

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  4 in total

Review 1.  Megaprostheses for the treatment of malignant bone tumours of the lower limbs.

Authors:  Christian Heisel; Stefan Kinkel; Ludger Bernd; Volker Ewerbeck
Journal:  Int Orthop       Date:  2006-09-12       Impact factor: 3.075

2.  Surgical technique: Unicondylar osteoallograft prosthesis composite in tumor limb salvage surgery.

Authors:  Hongbin Fan; Zheng Guo; Zhen Wang; Jing Li; Xiangdong Li
Journal:  Clin Orthop Relat Res       Date:  2012-07-03       Impact factor: 4.176

3.  Proximal femoral replacements for metastatic bone disease: financial implications for sarcoma units.

Authors:  Robert U Ashford; Sammy A Hanna; Derek H Park; Rob C Pollock; John A Skinner; Timothy W R Briggs; Stephen R Cannon
Journal:  Int Orthop       Date:  2009-07-15       Impact factor: 3.075

4.  Functional outcome after endoprosthetic limb-salvage therapy of primary bone tumours--a comparative analysis using the MSTS score, the TESS and the RNL index.

Authors:  P U Tunn; D Pomraenke; U Goerling; P Hohenberger
Journal:  Int Orthop       Date:  2007-08-15       Impact factor: 3.075

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.